Connecting European Neuroscience

Amalric, Marianne

Secretary General (2014 - 2016)

Curriculum Vitae

Education

1979
Master in Sciences (Biology) (University Paris XI)
1982
Doctorat PhD, Neuroscience (Université Paris VI)
1995
Habilitation in Neuroscience (eq. Professor) (University Aix-Marseille II)

Professional and academic career

Affiliation
1979
Master in Sciences (Biology) (University Paris XI)
1982
Doctorat PhD, Neuroscience (Université Paris VI)
1995
Habilitation in Neuroscience (eq. Professor) (University Aix-Marseille II)
2008-Present
Senior Scientist CNRS (1rt class), Head of Unit, CNRS UMR6155, Marseille
1996–2008
Senior Scientist CNRS (2nd class), Head of Unit, CNRS UMR6155, Marseille
1989-1996
Research Associate CNRS (1rt class)
1985-1989
Research Associate CNRS (2nd class)
1982-1985
Post-doctoral fellow (San Diego, USA)

Professional career
2001-Present
Team Head: Basal Ganglia Cognition and Physiopathology UMR7291 CNRS, Aix-Marseille University
1992-2001
Senior Researcher, CNRS UPR 9013, Marseille Research Associate. Functional Neuroscience Lab. CNRS UPR 28. Marseille
1986-1989
Research Associate. Neuro. and Neuropharm. of Developt. UA 1121 CNRS. University Paris XI
1983-1985
Post-doctoral fellow. Behavioral Neurobiology Lab. (Pr. FE Bloom) in “Salk Institute” and “Scripps Clinic and Research Foundation”, San Diego (USA)
1979-1982
Pre-doctoral training. Neurob. of Devel. (Pr. M. Imbert). CNRS LA 89. University Paris XI

Administrative and organisational experience

2012-2014
Vice-President of France Parkinson Association
2006–2009
President of Fondation de France Parkinson scientific committee
2007-2012
Member of Agence Nationale pour la Recherche (ANR) scientific committee
2005-Present
Member of CNRS/INSERM ATIP AVENIR grant reviewing committee
2001-2004
President of European Behavioural Pharmacology Society (EBPS)
1994-Present
Member of EBPS Executive Committee, General Secretary (2004-2007)
2004-2007
Member of Foundation de France Parkinson scientific committee
2002-2004
Member of French Neuroscience Society nomination committee
1999-2004
Member of IBAGS (International Basal Ganglia Society) Council
Member of FENS (Forum European Neuroscience Societies) scientific
committee Berlin (1998) and Brighton (2000)
1996–1998
Member of Human Frontier Science Program reviewing committee

Research interests

The team research interest is centered on neurological diseases, experimental therapeutics and neuroplasticity, focusing on basal ganglia-related disorders (BG). Ongoing projects are centered on Parkinson’s disease (PD) and preclinical evaluation of new treatment strategies with metabotropic glutamate receptors ligands or modulators of potassium channels in animal models of PD. The involvement of the BG in sensorimotor control and cognition is assessed by a combination of behavioural, pharmacological, cellular and optogenetic approaches.

Selected Publications

  • Lopez S, Jouve L, Turle-Lorenzo N, Kerkerian-Legoff L, Salin P, Amalric M. (2012). Antiparkinsonian action of a selective group III mGlu receptor agonist is associated with reversal of subthalamonigral overactivity. Neurobiol Dis. 2012 6:69-77 IF: 4.01
  • Goudet C, Vilar B, Courtiol T, Deltheil T, Bessiron T, Brabet I, Oueslati N, Rigault D, Bertrand HO, McLean H, Daniel H, Amalric M, Acher F, Pin JP. (2012). A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential. The FASEB J. 2012 26:1682-93. IF: 7.9.
  • Courtière A, Hardouin J, Burle B., Vidal F., Turle-Lorenzo N. Amalric M., Hasbroucq T (2011). Dynamics of executive control and motor deficits in Parkinsonian rats. J Neurosci. 31: 11929-11933. IF: IF:8.12
  • Moussa R, Poucet B, Amalric M, Sargolini F (2011) Contributions of dorsal striatal subregions to spatial alternation behaviour. Learning and memory.
    18: 444-451. IF:4.79
  • Beurrier C, Lopez S, Révy D, Selvam C, Goudet C, Lhérondel M, Gubellini P, Kerkerian-LeGoff L, Acher FC, Pin JP, Amalric M. (2009) Electrophysiological and behavioral evidences that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism. The FASEB J. 23:3619-3628; IF:7.12
  • Lopez S, Turle-Lorenzo N, Acher F, DeLeonibus E, Mele A, Amalric M (2007) Targeting group III metabotropic glutamate receptors produces complex behavioral effects in rodent models of Parkinson’s disease. J. Neurosci.
    27 :6701-6711. IF:8.12
  • Baunez C, Dias C, Cador M, Amalric M (2005). The subthalamic nucleus exerts an opposite control on cocaine and natural rewards. Nature Neuroscience 4 : 484-489

Amalric, Marianne

CNRS UMR7291, Laboratory of Cognitive Neurosciences
Aix-Marseille University
3 Place V. Hugo, Case C
13331 Marseille Cedex 03
France

Phone: +33 (0)413550935
Fax: +33 (0)413550958
E-mail: marianne.amalric@univ-amu.fr

loading